Table 3 Outcome comparison, period II vs. period III
From: Prognostic effects of treatment protocols for febrile convulsive status epilepticus in children
| Â | Period II n=48 | Period III n=36 | Risk difference (95% CI) | p-value |
|---|---|---|---|---|
PCPC scale score ≥2, n (%) | 2 (4.2) | 4 (11.1) | 6.9% (-3.5% to 13.8%) | 0.40 |
Final diagnosis | ||||
 AE, n (%) | 7 (14.6) | 4 (11.1) | -3.5% (-14.5% to 10.8%) | 0.75 |
  AESD, n (%) | 3 (6.2) | 3 (8.3) | 2.1% (-6.9% to 11.1%) | 1 |
  MERS, n (%) | 1 (2.1) | 0 (0) | -2.1 (-2.1% to 1.8%) | 1 |
  Unclassified AE, n (%) | 3 (6.3) | 1 (2.8) | -3.5% (-7.4% to 5.1%) | 0.63 |
 Febrile seizure, n (%) | 41 (85.4) | 32 (88.9) | 3.5% (-10.8% to 14.5%) | 0.75 |
Treatment-related complication | ||||
 VAP, n (%) | 3 (6.3) | 4 (11.1) | 4.9% (-5.8% to 13.9%) | 0.46 |